bilaterals.org logo
bilaterals.org logo

medicines

FTA undermines principle of affordable drugs for all
25-May-2004 FTA undermines principle of affordable drugs for all
The Australian Senate should delay implementing legislation for the Free Trade Agreement with the US. Countries such as Brazil and Thailand, with large generic pharmaceutical industries, are looking to Australia for leadership in countering this US bilateral push for global uniformly of high pharmaceutical prices through aggressive intellectual property (IP) protection.
Drugs May Tie Up FTAs
11-May-2004
Disagreements over trade in pharmaceuticals may bog down pending free trade agreements between the U.S. and foreign nations.
USA-Morocco deal may extend drug patents to 30 years
4-Apr-2004
A free trade agreement due to be signed between Morocco and the USA by the end of this year could threaten access to medicines, several non-governmental organisations (NGOs) warned last week.
FTA Would Hurt Thais, Expert Warns
28-Mar-2004
A free trade agreement with the United States would lead to a broader application of intellectual property rights that could hurt Thais — from farmers to internet users — an expert has warned.
TRIPS-plus through EFTA’s backdoor
20-Mar-2004
The Free Trade Agreements concluded between the four member states of the European Free Trade Association ¬(EFTA) - Switzerland, Norway, Iceland and Liechtenstein - and a number of developing countries contain provisions on the protection of intellectual property rights (IPRs) which go far beyond the obligations already imposed on these countries in the framework of the World Trade Organization (WTO).
Bilateralism in intellectual property
14-Mar-2004
This paper examines the way in which bilateral trade negotiations (Bilateral Investment Treaties and Bilateral Intellectual Property Agreements) are being used by the USA and others to build more extensive protection for intellectual property than that set out in the WTO TRIPS Agreement.